Latest Market News

Diablo Resources has confirmed multiple high-grade silver, gold, copper, and antimony systems at its Star Range Project in Utah, setting the stage for its maiden drilling campaign.

Predictive Discovery has secured a crucial court approval for its acquisition of Robex Resources, paving the way for the deal to close in early 2026 pending final regulatory consents.

Racura Oncology has launched a strategic collaboration with Emory University to investigate (E,E)-bisantrene’s potential to overcome resistance to osimertinib in EGFR-mutated non-small cell lung cancer. This partnership aims to bolster Racura’s HARNESS-1 clinical trial and strengthen its position in the competitive lung cancer treatment landscape.

Robex Resources has received final court approval for its merger with Predictive Discovery, setting the stage for completion in early 2026 pending regulatory consents. This move could reshape the future of Robex’s West African gold projects.

Ion Video Limited has completed significant restructuring, strengthened its Melbourne-based tech team, and raised $2.95 million, positioning itself for a technology relaunch in February 2026 with a cash runway extending to mid-2027.

Viking Mines reports promising high-grade tungsten oxide assay results from its Linka Tungsten Project in Nevada, reinforcing the project's potential amid soaring global scheelite prices.

Kinatico Limited has reported a robust 42% increase in its SaaS revenue for Q2FY26, driven by strong operational execution and the launch of its new Kinatico Compliance solution.

Bluescope Steel has announced a special unfranked dividend of AUD 1.00 per share, payable in late February 2026, signaling a notable return to shareholders outside its regular dividend schedule.

BlueScope announces a $1.00 per share unfranked special dividend, returning $438 million to shareholders from recent asset sales and working capital releases. The steelmaker signals a robust cash flow outlook with a planned capex reduction in FY2027.

Proteomics International Laboratories has appointed David Morris as CEO and Managing Director, marking a strategic shift towards commercialising its Promarker® diagnostic technology. Morris brings extensive global healthcare leadership experience to lead the company’s next growth phase.

ECS Botanics reports a $218k positive operating cash flow in Q2 FY26, driven by strong B2C growth and new product launches. The company also secured $1.95 million in funding to fuel European expansion and product development.

The Calmer Co. International Limited has reported its highest ever monthly sales of $910,767 in December 2025, driven by strong wholesale growth and expanding US market presence.